Gladman, DD: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Accrual of atherosclerotic vascular events in a multicentre inception SLE cohort

Urowitz, MB, Gladman, DD, Farewell, V., Su, J, RomeroâDiaz, J, Bae, SC, Fortin, PR, SanchezâGuerrero, J, Clarke, AE, Bernatsky, S, Gordon, C, Hanly, JG, Wallace, DJ, Isenberg, D, Rahman, A, Merril

Journal:

Arthritis & Rheumatology

Year:

2020

File:

PDF, 10.82 MB

2020

2

Development validation and reliability of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50

Z Touma,DD Gladman,MB Urowitz

Journal:

Arthritis Research & Therapy

Year:

2012

Language:

english

File:

PDF, 722 KB

english, 2012

3

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - FRI0522 The association between occupational-related mechanical stress and radiographic damage in psoriatic arthritis

Zhou, W, Cook, R, Chandran, V, Gladman, DD, Eder, L

Language:

english

File:

PDF, 471 KB

english

4

MS4 THE COST-EFFECTIVENESS OF ADDING INFLIXIMAB TO USUAL THERAPY IN THE TREATMENT OF PSORIATIC ARTHRITIS

CA Marra, A Maetzel, VT Farewell, AA Rashidi, P Shi, C Antoni, JB Wong, DD Gladman

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 59 KB

english, 2005

5

[Lupus Foundation of America 11th European Lupus Meeting, DÃ¼sseldorf, Germany, 21â24 March 2018, Abstract presentations - ()] S1d: Therapeutic strategies - S1D:5âSle disease activity index glucocorticosteroid index (sledai-2kg) identifies more responders than sledai-2k

Urowitz, M, Gladman, DD, Su, J, Anderson, NM, Touma, Z

File:

PDF, 980 KB

6

The nature and outcome of infection in systemic lupus erythematosus

Gladman, DD, Hussain, F, Ibañez, D, Urowitz, MB

Journal:

Year:

2002

Language:

english

File:

PDF, 132 KB

english, 2002

7

Pulmonary hypertension in systemic lupus

Johnson, SR, Gladman, DD, Urowitz, MB, Ibanez, D, Granton, JT

Journal:

Year:

2004

Language:

english

File:

PDF, 67 KB

english, 2004

8

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Oral Presentations - OP0202 Efficacy and safety of tofacitinib, an oral janus kinase inhibitor, in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: opal beyond, a randomised, double-blind, placebo-controlled, phase 3 trial

Gladman, DD, Rigby, WFC, Azevedo, VF, Behrens, F, Blanco, R, Kaszuba, A, Kudlacz, E, Wang, C, Menon, S, Hendrikx, T, Kanik, KS

Language:

english

File:

PDF, 1.02 MB

english

9

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Abstracts Accepted for Publication - AB0785 Consistent safety profile with up to 4 years of apremilast treatment: analysis of data from 1493 patients with psoriatic arthritis in 3 large, phase iii, long-term studies

Mease, PJ, Gladman, DD, Gomez-Reino, JJ, Hall, S, Kavanaugh, A, Lespessailles, E, Schett, G, Paris, M, Teng, L, Wollenhaupt, J

Language:

english

File:

PDF, 458 KB

english

10

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - FRI0509 Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, up to 24 months in patients with active psoriatic arthritis: interim data from opal balance, an open-label, long-term extension study

Nash, P, Coates, LC, Kivitz, AJ, Mease, PJ, Gladman, DD, Covarrubias-Cobos, JA, Fleishaker, D, Wang, C, Kudlacz, E, Menon, S, Hendrikx, T, Kanik, KS

Language:

english

File:

PDF, 230 KB

english

11

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - SAT0462 Secukinumab provides sustained pasdas related low disease activity in psoriatic arthritis: 2 year results from the future 2 study

Coates, LC, Gladman, DD, Nash, P, Fitzgerald, O, Kavanaugh, A, Rasouliyan, L, Pricorp, L, Ding, K, Gaillez, C

Language:

english

File:

PDF, 422 KB

english

12

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - FRI0498 Outcomes associated with achievement of various treatment targets in patients with psoriatic arthritis receiving adalimumab

Smolen, J, Aletaha, D, Gladman, DD, Zhang, Y, Ganz, F

Language:

english

File:

PDF, 289 KB

english

13

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - SAT0436 Durability of apremilast response in patients with psoriatic arthritis: long-term (208-week) results from the palace 1 trial

Kavanaugh, A, Gladman, DD, Gomez-Reino, JJ, Hall, S, Lespessailles, E, Mease, PJ, Schett, G, McIlraith, M, Delev, N, Paris, M, Teng, L, Wollenhaupt, J

Language:

english

File:

PDF, 447 KB

english

14

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Abstracts Accepted for Publication - AB0743 Low rates of major adverse cardiac events, malignancies, and serious infections in patients with psoriasis and psoriatic arthritis treated with apremilast for ≥156 weeks: pooled analysis from the esteem and palace 1-3 phase 3 trials

Kavanaugh, A, Augustin, M, Lespessailles, E, Papp, KA, Paris, M, Chen, R, Gladman, DD, Pariser, DM, Peris, K

Language:

english

File:

PDF, 395 KB

english

15

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - SAT0448 Apremilast treatment and long-term (up to 156 weeks) improvements in dactylitis and enthesitis in patients with psoriatic arthritis: analysis of a large database of the phase iii clinical development program

Gladman, DD, Kavanaugh, A, Gomez-Reino, JJ, Wollenhaupt, J, Cutolo, M, Schett, G, Lespessailles, E, McIlraith, M, Hu, C, Edwards, CJ, Birbara, CA, Mease, PJ

Language:

english

File:

PDF, 247 KB

english

16

Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations

Johnson, SR, Harvey, PJ, Floras, JS, Iwanochko, M, Ibanez, D, Gladman, DD, Urowitz, M

Journal:

Year:

2004

Language:

english

File:

PDF, 236 KB

english, 2004

17

[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - SAT0481 The relationship between the patient acceptable symptom state (PASS) and disease activity in patients with psoriatic arthritis (PSA)

Fei, JZ, Perruccio, A, Ye, Y, Gladman, DD, Chandran, V

Language:

english

File:

PDF, 265 KB

english

18

Shrinking lung syndrome in systemic lupus erythematosus: a single-centre experience

Deeb, M, Tselios, K, Gladman, DD, Su, J, Urowitz, MB

Journal:

Year:

2017

Language:

english

File:

PDF, 91 KB

english, 2017

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски